| 000 | 02940cam a2200373 a 4500 | ||
|---|---|---|---|
| 999 |
_c3308 _d3308 |
||
| 001 | 17688233 | ||
| 003 | OSt | ||
| 005 | 20191003171010.0 | ||
| 008 | 130405s2013 caua b 001 0 eng | ||
| 010 | _a 2013014051 | ||
| 020 | _a9781597565189 (pbk. : alk. paper) | ||
| 020 | _a1597565180 (pbk. : alk. paper) | ||
| 035 | _a(DNLM)101605613 | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRC523 _b.B39 2013 |
| 060 | 1 | 0 | _aWT 150 |
| 082 | 0 | 0 |
_a616.831 BAY T _223 |
| 100 | 1 |
_aBayles, Kathryn A., _d1942- |
|
| 245 | 1 | 0 |
_aMCI and Alzheimer's dementia : _bclinical essentials for assessment and treatment of cognitive-communication disorders / _cKathryn A. Bayles, author, Cheryl K. Tomoeda, author. |
| 260 |
_aSan Diego, CA : _bPlural Publishing, _c[2013] |
||
| 300 |
_axix, 209 pages : _billustrations ; _c23 cm |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aIntroduction Definition and discussion of the dementia syndrome and its significance in terms of prevalence and cost. MCI Defined Explanation of MCI, its various forms, the recently revised diagnostic criteria established by the NIH and the Alzheimer's Association, information about rate of conversion to AD, and a review of early changes in language and cognition. Alzheimer's Dementia Defined Diagnostic criteria, neuropathology, risk factors, effects on cognition and communication by stage of disease, and samples of the language of affected individuals by stage of disease. Assessment of MCI and AD The process of assessment, reviews of commonly used tests and severity measures, recommendations on tests for screening and comprehensive assessment, and differential diagnosis. Rationale for intervention Evidence from cognitive science for the involvement of SLPs in identifying individuals with MCI and AD and treating them directly and indirectly through caregiver counseling to sustain, improve, and/or maximize functioning. Treatment of MCI Options SLPs have for helping clients sustain function, including cognitive wellness programs. Direct Treatment of AD Treatment guidelines and evidence-based techniques for facilitating learning and information retrieval. Indirect Treatment of AD Modifications that SLPs can recommend and oversee regarding the physical and linguistic environment that will enable affected individuals to function at their highest level of ability. Specific recommendations are included about how to communicate with affected individuals and how to improve their ability to comprehend and express language. | ||
| 650 | 1 | 2 |
_aMild Cognitive Impairment _xdiagnosis. |
| 650 | 2 | 2 | _aAged. |
| 650 | 2 | 2 |
_aAlzheimer Disease _xdiagnosis. |
| 650 | 2 | 2 |
_aAlzheimer Disease _xtherapy. |
| 650 | 2 | 2 |
_aMild Cognitive Impairment _xtherapy. |
| 700 | 1 | _aTomoeda, Cheryl K. | |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cSTS |
||